Cargando…

FDA limits authorised use of Janssen COVID-19 vaccine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099335/
http://dx.doi.org/10.1007/s40278-022-14892-2
_version_ 1784706581909209088
collection PubMed
description
format Online
Article
Text
id pubmed-9099335
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90993352022-05-13 FDA limits authorised use of Janssen COVID-19 vaccine Reactions Weekly Unknown Springer International Publishing 2022-05-14 2022 /pmc/articles/PMC9099335/ http://dx.doi.org/10.1007/s40278-022-14892-2 Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Unknown
FDA limits authorised use of Janssen COVID-19 vaccine
title FDA limits authorised use of Janssen COVID-19 vaccine
title_full FDA limits authorised use of Janssen COVID-19 vaccine
title_fullStr FDA limits authorised use of Janssen COVID-19 vaccine
title_full_unstemmed FDA limits authorised use of Janssen COVID-19 vaccine
title_short FDA limits authorised use of Janssen COVID-19 vaccine
title_sort fda limits authorised use of janssen covid-19 vaccine
topic Unknown
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099335/
http://dx.doi.org/10.1007/s40278-022-14892-2